The benefit of biventricular pacing in appropriate patients with congestive heart failure (CHF) now has been established in terms of both morbidity and mortality. [1,2,3,4,5] Current criteria for ...
Conduction system pacing was found to be inferior to biventricular pacing for key outcomes in HFrEF with left bundle-branch ...
Two multicenter trials drew different conclusions about the value of conduction system relative to biventricular pacing for ...
The BLOCK HF trial demonstrated that, during continual cardiac pacing, adverse left ventricular remodelling and deterioration of systolic function occurred more frequently with right ventricular than ...
Patients with indications for cardiac resynchronization therapy (CRT) have better clinical outcomes when they undergo left bundle branch area pacing (LBBAP) rather than conventional biventricular ...
To the Editor: Yu et al. (Nov. 26 issue) 1 found that among patients with bradycardia, the left ventricular ejection fraction at 12 months was 7 percentage points lower in the patients who were ...
ST. PAUL, Minn.--(BUSINESS WIRE)--Aug. 25, 2004--St. Jude Medical, Inc. (NYSE:STJ) announced today U.S. Food and Drug Administration (FDA) approval and first implants of the Frontier(TM) II ...
The global biventricular pacemakers market is on a sustained growth trajectory, with 2024 revenues estimated at $2.27 billion, building on the $2.1 billion recorded in 2023. Analysts forecast the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results